Human OLFML3 ELISA Kit (V2LY-0626-LY4986)

Chen, H., Li, R., Bian, J., Li, X., Su, C., Wang, Y., ... & Zhang, H. (2024). OLFML3 suppresses trophoblast apoptosis via the PI3K/AKT pathway: A possible therapeutic target in preeclampsia. Placenta, 147, 1-11.

Qu, S., Huang, C., Zhu, T., Wang, K., Zhang, H., Wang, L., ... & Qi, S. (2023). OLFML3, as a potential predictor of prognosis and therapeutic target for glioma, is closely related to immune cell infiltration. View, 4(2), 20220052.

Stalin, J., Imhof, B. A., Coquoz, O., Jeitziner, R., Hammel, P., McKee, T. A., ... & Miljkovic-Licina, M. (2021). Targeting OLFML3 in colorectal cancer suppresses tumor growth and angiogenesis, and increases the efficacy of anti-PD1 based immunotherapy. Cancers, 13(18), 4625.

Mei, H., Zha, Z., Wang, W., Xie, Y., Huang, Y., Li, W., ... & Liu, J. (2021). Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist. Genome biology, 22, 1-24.

Oliver, J. A., Wright, H., Massidda, P. A., Burmeister, L. M., & Mellersh, C. S. (2020). A variant in OLFML3 is associated with pectinate ligament abnormality and primary closed‐angle glaucoma in Border Collies from the United Kingdom. Veterinary ophthalmology, 23(1), 25-36.

Pugh, C. A., Farrell, L. L., Carlisle, A. J., Bush, S. J., Ewing, A., Trejo-Reveles, V., ... & Summers, K. M. (2019). Arginine to glutamine variant in olfactomedin like 3 (OLFML3) is a candidate for severe goniodysgenesis and glaucoma in the Border Collie dog breed. G3: Genes, Genomes, Genetics, 9(3), 943-954.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols